The inflammatory response in myocardial injury, repair, and remodelling.
TLDR
Biomarker-based approaches are needed to identify patients with distinct pathophysiologic responses and to rationally implement inflammation-modulating strategies in patients with myocardial infarction.Abstract:
Myocardial infarction triggers an intense inflammatory response that is essential for cardiac repair, but which is also implicated in the pathogenesis of postinfarction remodelling and heart failure. Signals in the infarcted myocardium activate toll-like receptor signalling, while complement activation and generation of reactive oxygen species induce cytokine and chemokine upregulation. Leukocytes recruited to the infarcted area, remove dead cells and matrix debris by phagocytosis, while preparing the area for scar formation. Timely repression of the inflammatory response is critical for effective healing, and is followed by activation of myofibroblasts that secrete matrix proteins in the infarcted area. Members of the transforming growth factor β family are critically involved in suppression of inflammation and activation of a profibrotic programme. Translation of these concepts to the clinic requires an understanding of the pathophysiological complexity and heterogeneity of postinfarction remodelling in patients with myocardial infarction. Individuals with an overactive and prolonged postinfarction inflammatory response might exhibit left ventricular dilatation and systolic dysfunction and might benefit from targeted anti-IL-1 or anti-chemokine therapies, whereas patients with an exaggerated fibrogenic reaction can develop heart failure with preserved ejection fraction and might require inhibition of the Smad3 (mothers against decapentaplegic homolog 3) cascade. Biomarker-based approaches are needed to identify patients with distinct pathophysiologic responses and to rationally implement inflammation-modulating strategies.read more
Citations
More filters
Posted ContentDOI
Myocardial damage induced by a single high dose of isoproterenol in C57Bl/6J mice triggers a persistent adaptive immune response against the heart.
Elvira Forte,Mona Panahi,Fu Siong Ng,Joseph J. Boyle,Jane Branca,Olivia Bedard,Muneer G. Hasham,Lindsay Benson,Sian E. Harding,Nadia Rosenthal,Susanne Sattler +10 more
TL;DR: It is shown that isoproterenol treatment induces myocardial damage reminiscent of human type 2 MI, which is followed by a persistent adaptive immune response against the heart in the serum 12 weeks after the initial injury.
Journal ArticleDOI
Construction of a Band‐Aid Like Cardiac Patch for Myocardial Infarction with Controllable H2S Release
Weirun Li,Peier Chen,Yuxuan Pan,Ling Lu,Xiao Ning,Jiamin Liu,Jintao Wei,Minsheng Chen,Peng Zhao,Caiwen Ou +9 more
TL;DR: This engineered cardiac patch can relieve inflammation and promote angiogenesis after MI, and thereby recover heart function, providing a promising therapeutic strategy for MI treatment.
Regulation of the anti-inflammatory properties of MSCspheroids by matrix metalloproteinases
TL;DR: In vivo work showed that intra-peritoneal injection of MSC spheroids reduced the inflammatory reaction of mice to the pro-inflammatory agent zymosan, suggesting a deeper understanding of specific MMPs mechanism of action could lead to potential MSC-based anti-inflammatory therapeutics for myocardial infarction.
Journal ArticleDOI
Antioxidant and Anti-Inflammatory Effects of Bischofia javanica (Blume) Leaf Methanol Extracts through the Regulation of Nrf2 and TAK1.
Sewoong Lee,Jain Ha,Ji Young Park,Eunjeong Kang,Sung-Hyun Jeon,Sang Beom Han,Sri Ningsih,Jin Hyub Paik,Sayeon Cho +8 more
TL;DR: In this article, the antioxidant and anti-inflammatory mechanisms of methanol extracts of B. javanica leaves were analyzed in vitro and in vivo, and it was shown that MBJ decreased nitric oxide (NO) production and the expression of pro-inflammatory cytokines, including interleukin (IL)-1β, IL-6, and tumor necrosis factorα, in lipopolysaccharide (LPS)-treated RAW 264.7 cells.
Journal ArticleDOI
Dystrophin and metalloproteinase 9 in myocardial ischemia: A post-mortem immunohistochemical study.
Cristina Mondello,Elvira Ventura Spagnolo,Giovanni Bartoloni,Angela Alibrandi,Luigi Cardia,Daniela Sapienza,Patrizia Gualniera,Alessio Asmundo +7 more
TL;DR: In this article, the authors evaluated the expression of dystrophin and MMP-9 in cases of sudden cardiac death (SCD) due to coronary atherosclerotic disease (CAD) in order to analyze the characteristics and the chronology of their expression, providing evidence on the possible role in post-mortem diagnosis of myocardial ischemia.
References
More filters
Journal ArticleDOI
Getting to the site of inflammation: the leukocyte adhesion cascade updated
TL;DR: This Review focuses on new aspects of one of the central paradigms of inflammation and immunity — the leukocyte adhesion cascade.
Journal ArticleDOI
DAMPs, PAMPs and alarmins: all we need to know about danger
TL;DR: The term “alarmin” is proposed to categorize such endogenous molecules that signal tissue and cell damage, and can be considered subgroups of a larger set, the damage‐associated molecular patterns (DAMPs).
Journal ArticleDOI
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
Harvey D. White,R M Norris,Michael A. Brown,Peter W.T. Brandt,Ralph M.L. Whitlock,Chris J. Wild +5 more
TL;DR: Volume, ejection fractions, and severity of coronary arterial occlusions and stenoses in 605 male patients under 60 years of age at 1 to 2 months after a first or recurrent myocardial infarction showed that end-systolic volume had greater predictive value for survival than end-diastolic volume or ejection fraction.
Journal ArticleDOI
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
TL;DR: Left ventricular end-diastolic and end-systolic volume and ejection fraction data provide support for the beneficial effects of therapeutic agents such as angiotensin-converting enzyme (ACE) inhibitors and beta-adrenergic blocking agents on the remodeling process.
Related Papers (5)
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker,Brendan M. Everett,Tom Thuren,Jean G. MacFadyen,William Chang,Christie M. Ballantyne,Francisco H. Fonseca,Jose C. Nicolau,Wolfgang Koenig,Stefan D. Anker,John J.P. Kastelein,Jan H. Cornel,Prem Pais,Daniel Pella,Jacques Genest,Renata Cifkova,Alberto J. Lorenzatti,Tamás Forster,Zhanna Kobalava,Luminita Vida-Simiti,Marcus Flather,Hiroaki Shimokawa,Hisao Ogawa,Mikael Dellborg,Paulo Roberto Ferreira Rossi,Roland P.T. Troquay,Peter Libby,Robert J. Glynn +27 more